In a landmark move that signals a significant shift in mainstream acceptance of psychedelic medicine, the Canadian Cancer Society (CCS) has awarded a $5 million grant to fund groundbreaking research on psychedelic-assisted therapy for cancer patients. This historic investment—the largest ever for psychedelic research in...
In the evolving landscape of mental health treatment, psychedelic-assisted therapy has emerged as a promising frontier, particularly for conditions that have proven resistant to conventional treatments. While much attention has focused on psychedelics for post-traumatic stress disorder (PTSD), a related but distinct condition—moral injury—may also...
In the vast and mysterious terrain of psychedelic experiences, few substances create worlds as vivid, complex, and populated as N,N-dimethyltryptamine, commonly known as DMT. Often referred to as "the spirit molecule," this powerful psychedelic compound produces experiences so profound and otherworldly that they challenge our...
In the quiet darkness behind closed eyelids, most of us experience little more than the faint phosphenes that dance across our visual field—those fleeting specks of light that appear when we press our palms against our eyes or sit in complete darkness. But for those...